Glenmark Pharmaceuticals initiates phase II study of GBR 500 for ulcerative colitis
The trial is part of a strategic global collaboration between Glenmark and Sanofi
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.